Ignite Creation Date:
2025-12-24 @ 11:36 PM
Ignite Modification Date:
2026-03-06 @ 10:09 PM
Study NCT ID:
NCT06839456
Status:
RECRUITING
Last Update Posted:
2025-03-25
First Post:
2025-02-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Sponsor:
Children's Hospital of Philadelphia
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
24-022264
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None